Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_assertion type Assertion NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_head.
- NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_assertion description "[The aims of the study were: 1) to determine the genotype of NAT2 in patients with sporadic PD with dementia and in patients with sporadic AD; 2) to evaluate the relationship between the genotype of NAT2 and the age at the onset of the disease, the extent of dementia, and the dose and side effects of L-dopa (in PD patients only); 3) to evaluate the predispositions to PD and AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_provenance.
- NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_assertion evidence source_evidence_literature NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_provenance.
- NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_assertion SIO_000772 18033638 NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_provenance.
- NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_assertion wasDerivedFrom befree-20140225 NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_provenance.
- NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_assertion wasGeneratedBy ECO_0000203 NP551509.RAJpQMHe_Zc6_m2cE1wLoNcVYMk8ocUL85ASufD6pQPMo130_provenance.